Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N. P., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,013 · see citing works

Clinical practice guidelines : directions for a new program

Field, M. J., & Lohr, K. N. (1990) · Cited by 1,426 · see citing works

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans

Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213 · see citing works

Practice Guidelines for the Management of Cryptococcal Disease

Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,101 · see citing works

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H. A., Leonard, J. M., Fields, B. T., Bradshaw, M. W., Haywood, H. B., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907193010303 · Cited by 861 · see citing works

Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T. M., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 808 · see citing works

Clinical Practice Guidelines

Institute of Medicine (1990) · National Academies Press eBooks · doi:10.17226/1626 · Cited by 807 · see citing works

A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)

Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M. W., MacDougall, L., Boekhout, T., Kwon-Chung, K. J., & Meyer, W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402981101 · Cited by 758 · see citing works

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., Dupont, B., Torre‐Cisneros, J., Just‐Nübling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374557 · Cited by 672 · see citing works

Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole Therapy

Pappas, P. G., Perfect, J. R., Cloud, G. A., Larsen, R. A., Pankey, G. A., Lancaster, D. J., Henderson, H. M., Kauffman, C. A., Haas, D. W., Saccente, M., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322597 · Cited by 640 · see citing works

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

Shelburne, S. A., Visnegarwala, F., Darcourt, J. G., et al. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 633 · see citing works

Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis

Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P. A., Grieco, M. H., Sharkey, P. K., Thompson, S. E., Sugar, A. M., Tuazon, C. U., Fisher, J. F., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260202 · Cited by 625 · see citing works

Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

Zolopa, A. R., Andersen, J., Komarow, L., Sanne, I., Sanchez, A., Hogg, E., Suckow, C., Powderly, W. G., & for the ACTG A5164 study team (2009) · PLoS ONE · doi:10.1371/journal.pone.0005575 · Cited by 560 · see citing works

Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak

Fraser, J. A., Giles, S. S., Wenink, E. C., Geunes-Boyer, S. G., Wright, J. R., Diezmann, S., Allen, A., Stajich, J. E., Dietrich, F. S., Perfect, J. R., et al. (2005) · Nature · doi:10.1038/nature04220 · Cited by 499 · see citing works

The Periodic Health Examination

Frappier-Davignon, L. (1934) · New England Journal of Medicine · doi:10.1056/nejm193401252100413 · Cited by 488 · see citing works

Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis

Graybill, J. R., Sobel, J. D., Saag, M. S., van der Horst, C., Powderly, W. G., Cloud, G., Riser, L., Hamill, R. J., Dismukes, W. E., & NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups (2000) · Clinical Infectious Diseases · doi:10.1086/313603 · Cited by 484 · see citing works

Clinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformans

Speed, B. R., & Dunt, D. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.28 · Cited by 480 · see citing works

Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New Zealand

Chen, W., Sorrell, T. C., Nimmo, G. R., Speed, B. R., Currie, B. J., Ellis, D., Marriott, D. J. E., Pfeiffer, T., Parr, D. H., & Byth, K. (2000) · Clinical Infectious Diseases · doi:10.1086/313992 · Cited by 467 · see citing works

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 466 · see citing works

The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000

Mirza, S. A., Phelan, M., Rimland, D., Graviss, E. A., Hamill, R. J., Brandt, M. E., Gardner, T. J., Sattah, M., de León, G. P., Baughman, W. S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/368091 · Cited by 455 · see citing works

Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six Weeks

Dismukes, W. E., Cloud, G. A., Gallis, H. A., Kerkering, T. M., Medoff, G., Craven, P. C., Kaplowitz, L. G., Fisher, J. F., Gregg, C. R., Bowles, C. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170602 · Cited by 416 · see citing works

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

French, N., Gray, K. J., Watera, C., Nakiyingi, J., Lugada, E., Moore, M. V., Lalloo, D. G., WHITWORTH, J. A. G., & Gilks, C. F. (2002) · AIDS · doi:10.1097/00002030-200205030-00009 · Cited by 415 · see citing works

Cryptococcosis

Chayakulkeeree, M., & Perfect, J. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.001 · Cited by 396 · see citing works

Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome

Mitchell, D., Sorrell, T. C., Allworth, A. M., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.611 · Cited by 378 · see citing works

Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study

Dromer, F., Mathoulin-Pélissier, S., Launay, O., Lortholary, O., & the French Cryptococcosis Study Group (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040021 · Cited by 374 · see citing works

Fluconazole Compared with Amphotericin B plus Flucytosine for Cryptococcal Meningitis in AIDS

Larsen, R. A., Leal, M. A. E., & Chan, L. S. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-183 · Cited by 359 · see citing works

A Controlled Trial of Fluconazole or Amphotericin B to Prevent Relapse of Cryptococcal Meningitis in Patients with the Acquired Immunodeficiency Syndrome

Powderly, W. G., Saag, M. S., Cloud, G. A., Robinson, P. A., Meyer, R. D., Jacobson, J. M., Graybill, J. R., Sugar, A. M., McAuliffe, V. J., Follansbee, S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261203 · Cited by 351 · see citing works

Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome

Husain, S., Wagener, M. M., & Singh, N. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010302 · Cited by 328 · see citing works

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

Lortholary, O., Fontanet, A. L., Mémain, N., Martin, A., Sitbon, K., & Dromer, F. (2005) · AIDS · doi:10.1097/01.aids.0000174450.70874.30 · Cited by 321 · see citing works

(1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus ( Basidiomycota, Hymenomycetes, Tremellomycetidae )

Kwon-Chung, K. J., Boekhout, T., Fell, J. W., et al. (2002) · Taxon · doi:10.2307/1555045 · Cited by 320 · see citing works

A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321102 · Cited by 318 · see citing works

Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa

Jarvis, J. N., Lawn, S. D., Vogt, M., Bangani, N., Wood, R., & Harrison, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/597262 · Cited by 315 · see citing works

Cryptococcus neoformans Infection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome

Husain, S., Wagener, M. M., & Singh, N. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.017302 · Cited by 313 · see citing works

The Role of Immune Reconstitution Inflammatory Syndrome in AIDS‐RelatedCryptococcus neoformansDisease in the Era of Highly Active Antiretroviral Therapy

Shelburne, S. A., Darcourt, J. G., White, A. C., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428618 · Cited by 305 · see citing works

A Placebo-Controlled Trial of Maintenance Therapy with Fluconazole after Treatment of Cryptococcal Meningitis in the Acquired Immunodeficiency Syndrome

Bozzette, S. A., Larsen, R. A., Chiu, J., Leal, M. A. E., Jacobsen, J., Rothman, P. B., Robinson, P. A., Gilbert, G. S., McCutchan, J. A., Tilles, J. G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240902 · Cited by 299 · see citing works

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis

Leenders, A. C. A. P., Reiss, P., Portegies, P., Clezy, K. R., Hop, W. C. J., Hoy, J., Borleffs, J. C. C., Allworth, T., Kauffmann, R. H., Jones, P., et al. (1997) · AIDS · doi:10.1097/00002030-199712000-00010 · Cited by 287 · see citing works

The periodic health examination. Canadian Task Force on the Periodic Health Examination.

(1979) · PubMed Central · Cited by 281 · see citing works

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

Bicanic, T. A., Meintjes, G., Wood, R., Hayes, M., Rebe, K. B., Bekker, L., & Harrison, T. S. (2007) · Clinical Infectious Diseases · doi:10.1086/518607 · Cited by 271 · see citing works

Cryptococcus neoformans in Organ Transplant Recipients: Impact of Calcineurin‐Inhibitor Agents on Mortality

Singh, N., Alexander, B. D., Lortholary, O., Dromer, F., Gupta, K. L., John, G. T., Busto, R. D., Klintmalm, G. B. G., Somani, J., Lyon, G. M., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511438 · Cited by 263 · see citing works

The Evolution of Pulmonary Cryptococcosis

Kerkering, T. M., DUMA, R. J., & SHADOMY, S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-5-611 · Cited by 260 · see citing works

An Immune Reconstitution Syndrome-Like Illness Associated withCryptococcus neoformans Infection in Organ Transplant Recipients

Singh, N. R., Lortholary, O., Alexander, B. D., Gupta, K. L., John, G. T., Pursell, K. J., Munoz, P., Klintmalm, G. B. G., Stosor, V., Busto, R. D., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430606 · Cited by 249 · see citing works

Activity of posaconazole in the treatment of central nervous system fungal infections

Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P. G., Chapman, S. W., Hare, R. S., & Hardalo, C. J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki288 · Cited by 249 · see citing works

Fluconazole-induced congenital anomalies in three infants

Pursley, T. J., Blomquist, I. K., Abraham, J., Andersen, H. F., & Bartley, J. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.336 · Cited by 246 · see citing works

A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis

Saag, M. S., Cloud, G. A., Graybill, J. R., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515110 · Cited by 246 · see citing works

Primary Cutaneous Cryptococcosis: A Distinct Clinical Entity

Neuville, S., Dromer, F., Morin, O., Dupont, B., Ronin, O., Lortholary, O., & the French Cryptococcosis Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/345956 · Cited by 244 · see citing works

Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis

Stamm, A. M., Diasio, R. B., Dismukes, W. E., Shadomy, S., Cloud, G. A., Bowles, C. A., Karam, G. H., & Espinel‐Ingroff, A. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90691-7 · Cited by 243 · see citing works

Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans

Tomecki, K. J. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80336-2 · Cited by 239 · see citing works

Epidemiology of Cryptococcosis in France: A 9-Year Survey (1985-1993)

Dromer, F., Mathoulin, S., Dupont, B., Laporte, A., & French Cryptococcosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.82 · Cited by 238 · see citing works

Antimicrobial Therapy and Vaccines

Weber (2002) · Cited by 237 · see citing works

High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial

Bicanic, T. A., Wood, R., Meintjes, G., Rebe, K. B., Brouwer, A. E., Loyse, A., Bekker, L., Jaffar, S. S., & Harrison, T. S. (2008) · Clinical Infectious Diseases · doi:10.1086/588792 · Cited by 231 · see citing works

Immune reconstitution syndrome associated with opportunistic mycoses

Singh, N., & Perfect, J. R. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70085-3 · Cited by 224 · see citing works

Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients

Hakim, J., Gangaidzo, I. T., Heyderman, R. S., Mielke, J., Mushangi, E., Taziwa, A., Robertson, V. J., Musvaire, P., & Mason, P. R. (2000) · AIDS · doi:10.1097/00002030-200007070-00013 · Cited by 222 · see citing works

Symptomatic Relapse of HIV‐Associated Cryptococcal Meningitis after Initial Fluconazole Monotherapy: The Role of Fluconazole Resistance and Immune Reconstitution

Bicanic, T. A., Harrison, T. S., Niepieklo, A., Dyakopu, N., & Meintjes, G. (2006) · Clinical Infectious Diseases · doi:10.1086/507895 · Cited by 222 · see citing works

Immunocompromised Hosts: Cryptococcosis in Solid Organ Transplant Recipients: Current State of the Science

Singh, N., Dromer, F., Perfect, J. R., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/592690 · Cited by 220 · see citing works

Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections

RAAD, I. I., Graybill, J. R., Bustamante, A. B., Cornely, O. A., Gaona-Flores, V. A., Afif, C., Graham, D. R., Greenberg, R. N., Hadley, S., Langston, A. A., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/504328 · Cited by 217 · see citing works

Itraconazole Therapy for Cryptococcal Meningitis and Cryptococcosis

Denning, D. W. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100107024 · Cited by 210 · see citing works

Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda

Liechty, C. A., Solberg, P., Were, W. A., Ekwaru, J. P., Ransom, R., Weidle, P. J., Downing, R., Coutinho, A., & Mermin, J. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01874.x · Cited by 206 · see citing works

Immune Reconstitution Syndrome and Exacerbation of Infections after Pregnancy

Singh, N., & Perfect, J. R. (2007) · Clinical Infectious Diseases · doi:10.1086/522182 · Cited by 206 · see citing works

Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis

Pappas, P. G., Bustamante, B., Ticona, E., Hamill, R. J., Johnson, P. C., Reboli, A., Aberg, J., Hasbun, R., & Hsu, H. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/420829 · Cited by 202 · see citing works

Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS

Larsen, R. A., Bozzette, S. A., Jones, B. E., Haghighat, D., Leal, M. A., Forthal, D. N., Bauer, M., Tilles, J. G., McCutchan, J. A., & Leedom, J. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.4.741 · Cited by 202 · see citing works

Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda

Longley, N., Muzoora, C. K., Taseera, K., Mwesigye, J., Rwebembera, J., Chakera, A. J., Wall, E. C., Andia, I., Jaffar, S. S., & Harrison, T. S. (2008) · Clinical Infectious Diseases · doi:10.1086/593194 · Cited by 201 · see citing works

Amphotericin B Lipid Complex Compared with Amphotericin B in the Treatment of Cryptococcal Meningitis in Patients with AIDS

Sharkey, P. K., Graybill, J. R., Johnson, E. S., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.315 · Cited by 199 · see citing works

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

Lortholary, O., Poizat, G., Zeller, V., Neuville, S., Boibieux, A., Alvarez, M., Dellamonica, P., Botterel, F., Dromer, F., & Chêne, G. (2006) · AIDS · doi:10.1097/01.aids.0000252060.80704.68 · Cited by 197 · see citing works

Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures

Bicanic, T. A., Brouwer, A. E., Meintjes, G., Rebe, K. B., Limmathurotsakul, D., Chierakul, W., Teparrakkul, P., Loyse, A., White, N. J., Wood, R., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832605fe · Cited by 194 · see citing works

Immune Reconstitution Cryptococcosis after Initiation of Successful Highly Active Antiretroviral Therapy

Jenny-Avital, E. R., & Abadi, M. A. (2002) · Clinical Infectious Diseases · doi:10.1086/344467 · Cited by 186 · see citing works

Pulmonary Cryptococcosis in Patients Without HIV Infection

Aberg, J. A., Mundy, L. M., & Powderly, W. G. (1999) · CHEST Journal · doi:10.1378/chest.115.3.734 · Cited by 185 · see citing works

Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions

Mwaba, P. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.914.769 · Cited by 184 · see citing works

The Periodic Health Examination: 1980

Delbanco, T. L., & TAYLOR, W. C. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-251 · Cited by 183 · see citing works

Cryptococcosis in Organ Transplant Recipients: An Overview

Vilchez, R. A., Fung, J. J., & Kusne, S. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20701.x · Cited by 179 · see citing works

Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study

McKinsey, D. S., Wheat, L. J., Cloud, G. A., Pierce, M. A., Black, J. R., Bamberger, D. M., Goldman, M., Thomas, C. J., Gutsch, H. M., Moskovitz, B. L., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514744 · Cited by 177 · see citing works

Antimicrobial Therapy and Vaccines

Venkatesan, P. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.305 · Cited by 175 · see citing works

Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease

Baddley, J. W., Perfect, J. R., Oster, R. A., Larsen, R. A., Pankey, G. A., Henderson, H., Haas, D. W., Kauffman, C. A., Patel, R., Zaas, A. K., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0529-z · Cited by 172 · see citing works

Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection

Aller, A. I., Martín‐Mazuelos, E., Lozano, F., Gómez-Mateos, J. M., Steele‐Moore, L., Holloway, W. J., Gutiérrez, M. J., Recio, F., & Espinel-Ingroff, A. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1544-1548.2000 · Cited by 171 · see citing works

Immune Reconstitution Syndrome After Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Thai Children

Puthanakit, T., Oberdorfer, P., Akarathum, N., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000195618.55453.9a · Cited by 163 · see citing works

Are Adverse Events of Nevirapine and Efavirenz Related to Plasma Concentrations?

2NN Study Group, Kappelhoff, B. S., van Leth, F., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000404 · Cited by 161 · see citing works

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Singh, N., Alexander, B., Lortholary, O., Dromer, F., Gupta, K., John, G., del Busto, R., Klintmalm, G., Somani, J., Lyon, G., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/524738 · Cited by 160 · see citing works

Combined Therapy with Amphotericin B and 5-Fluorocytosine for Candida Meningitis

Smego, R. A., Perfect, J. R., & Durack, D. T. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.6.791 · Cited by 159 · see citing works

Persistent Cryptococcus neoformans Infection of the Prostate after Successful Treatment of Meningitis

Larsen, R. A., Bozzette, S., McCutchan, J. A., Chiu, J., Leal, M. A., Richman, D. D., & California Collaborative Treatment Group (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-2-125 · Cited by 150 · see citing works

Pulmonary Cryptococcosis in Nonimmunocompromised Patients

Nadrous, H. F., Antonios, V., Terrell, C. L., et al. (2003) · CHEST Journal · doi:10.1016/s0012-3692(15)31671-8 · Cited by 148 · see citing works

Safety, Plasma Concentrations, and Efficacy of High-Dose Fluconazole in Invasive Mold Infections

Anaissie, E. J., Kontoyiannis, D. P., Huls, C. E., Vartivarian, S. E., Karl, C., Prince, R. A., Bosso, J. A., & Bodey, G. P. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.2.599 · Cited by 147 · see citing works

Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients

Micol, R., Lortholary, O., Sar, B., Laureillard, D., Ngeth, C., Dousset, J., Chanroeun, H., Ferradini, L., Guerin, P. J., Dromer, F., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed32c · Cited by 144 · see citing works

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis

Dromer, F., Bernède‐Bauduin, C., Guillemot, D., Lortholary, O., & for the French Cryptococcosis Study Group (2008) · PLoS ONE · doi:10.1371/journal.pone.0002870 · Cited by 143 · see citing works

Catastrophic Visual Loss Due to Cryptococcus neoformans Meningitis

Rex, J. H., Larsen, R. A., Dismukes, W. E., et al. (1993) · Medicine · doi:10.1097/00005792-199307000-00001 · Cited by 142 · see citing works

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

Witt, M. D., Lewis, R. J., Larsen, R. A., Milefchik, E. N., Leal, M. A. E., Haubrich, R., Richie, J., Edwards, J. E., & Ghannoum, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.322 · Cited by 136 · see citing works

Reducing Intracranial Pressure May Increase Survival among Patients with Bacterial Meningitis

Lindvall, P., Ahlm, C., Ericsson, M., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380970 · Cited by 134 · see citing works

Pulmonary Cryptococcosis: Localized and Disseminated Infections in 27 Patients with AIDS

Meyohas, M., Roux, P., Bollens, D., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.628 · Cited by 133 · see citing works

Discontinuation of Secondary Prophylaxis for Cryptococcal Meningitis in Human Immunodeficiency Virus–Infected Patients Treated with Highly Active Antiretroviral Therapy: A Prospective, Multicenter, Randomized Study

Vibhagool, A., Sungkanuparph, S., Mootsikapun, P., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374849 · Cited by 133 · see citing works

Serologic Evidence for Reactivation of Cryptococcosis in Solid-Organ Transplant Recipients

Saha, D. C., Goldman, D. L., Shao, X., Casadevall, A., Husain, S., Limaye, A. P., Lyon, M. G., Somani, J., Pursell, K. J., Pruett, T. L., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00242-07 · Cited by 133 · see citing works

Combination Therapy with Fluconazole and Flucytosine for Cryptococcal Meningitis in Ugandan Patients with AIDS

Mayanja‐Kizza, H., Oishi, K., Mitarai, S., Yamashita, H., Nalongo, K., Watanabe, K., Izumi, T., Ococi-Jungala, Augustine, K., Mugerwa, R. D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516372 · Cited by 128 · see citing works

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis

de Gans, J., Portegies, P., Tiessens, G., Schattenkerk, J. K. M. E., van Boxtel, C. J., Ketel, R. J. V., & Stam, J. (1992) · AIDS · doi:10.1097/00002030-199202000-00007 · Cited by 124 · see citing works

Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients with AIDS Treated with Highly Active Antiretroviral Therapy: An International Observational Study

Mussini, C., Pezzotti, P., Miró, J. M., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381261 · Cited by 124 · see citing works

The Poor Prognosis of Central Nervous System Cryptococcosis among Nonimmunosuppressed Patients: A Call for Better Disease Recognition and Evaluation of Adjuncts to Antifungal Therapy

Ecevit, İ. Z., Clancy, C. J., Schmalfuss, I. M., & Nguyen, M. H. (2006) · Clinical Infectious Diseases · doi:10.1086/503570 · Cited by 121 · see citing works

Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans

Thompson, G. R., Wiederhold, N. P., Fothergill, A. W., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01216-08 · Cited by 121 · see citing works

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Acetazolamide for the Treatment of Elevated Intracranial Pressure in Cryptococcal Meningitis

Newton, P. N., Thai, L. H., Tip, N. Q., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/342299 · Cited by 121 · see citing works

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81975-4 · Cited by 120 · see citing works

Comparison of the Efficacy of Amphotericin B and Fluconazole in the Treatment of Cryptococcosis in Human Immunodeficiency Virus-Negative Patients: Retrospective Analysis of 83 Cases

Dromer, F., Mathoulin, S., Dupont, B., Brugière, O., Letenneur, L., & French Cryptococcosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s154 · Cited by 120 · see citing works

Antifungal Therapy During Pregnancy

King, C. T., Rogers, P. D., Cleary, J. D., & Chapman, S. W. (1998) · Clinical Infectious Diseases · doi:10.1086/514977 · Cited by 120 · see citing works

Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS

Coker, R. J., Viviani, M. A., Gazzard, B., Pont, B. D., Pohle, H. D., Murphy, S. M., Atouguia, J., Champalimaud, J. L., & Harris, J. R. W. (1993) · AIDS · doi:10.1097/00002030-199306000-00011 · Cited by 119 · see citing works

Cryptococcal Skeletal Infections: Case Report and Review

Behrman, R. E., Masci, J. R., & Nicholas, P. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.181 · Cited by 119 · see citing works

Pharmacokinetics and Pharmacodynamics of Antifungals

Andes, D. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.007 · Cited by 115 · see citing works

Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence

McCarthy, K. M., Morgan, J., Wannemuehler, K. A., Mirza, S. A., Gould, S. M., Mhlongo, N., Moeng, P., Maloba, B. R., Crewe-Brown, H. H., Brandt, M. E., et al. (2006) · AIDS · doi:10.1097/qad.0b013e3280106d6a · Cited by 115 · see citing works

Pulmonary Cryptococcosis After Initiation of Anti-Tumor Necrosis Factor-α Therapy

Hage, C. A., Wood, K. L., Winer-Muram, H. T., Wilson, S. J., Sarosi, G. A., & Knox, K. S. (2003) · CHEST Journal · doi:10.1378/chest.124.6.2395 · Cited by 113 · see citing works

Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era

Charlier, C., Dromer, F., Lévêque, C., Chartier, L., Cordoliani, Y., Fontanet, A. L., Launay, O., Lortholary, O., & for the French Cryptococcosis Study Group (2008) · PLoS ONE · doi:10.1371/journal.pone.0001950 · Cited by 110 · see citing works

Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study

D, S. S. M., Filler, S. G., Chetchotisakd, P., Pappas, P. G., Nolen, T. L., Manosuthi, W., Anekthananon, T., Morris, M. I., Supparatpinyo, K., Kopetskie, H., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605497 · Cited by 109 · see citing works

Cryptococcosis in Children with AIDS

Abadi, J., Nachman, S., Kressel, A. B., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515130 · Cited by 108 · see citing works

Treatment of Hydrocephalus Secondary to Cryptococcal Meningitis by Use of Shunting

Park, M. K., Hospenthal, D. R., & Bennett, J. E. (1999) · Clinical Infectious Diseases · doi:10.1086/515161 · Cited by 104 · see citing works

Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with Cryptococcosis

Dannaoui, É., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F., & the French Cryptococcosis Study Group (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-05 · Cited by 102 · see citing works

Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions

Mwaba, P., Mwansa, J. K., Chintu, C., et al. (2001) · Postgraduate Medical Journal · doi:10.1136/pgmj.77.914.769 · Cited by 98 · see citing works

Cryptococcosis and Idiopathic CD4 Lymphocytopenia

Zonios, D. I., Falloon, J., Huang, C. Y., Chaitt, D. G., & Bennett, J. E. (2007) · Medicine · doi:10.1097/md.0b013e31803b52f5 · Cited by 97 · see citing works

Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature

Skiest, D. J., Hester, L., & Hardy, R. D. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.02.031 · Cited by 95 · see citing works

The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire

Desmet, P., Kayembe, K. D., & Vroey, C. D. (1989) · AIDS · doi:10.1097/00002030-198902000-00004 · Cited by 94 · see citing works

High-Dose Fluconazole Therapy for Cryptococcal Meningitis in Patients with AIDS

Menichetti, F., Fiorio, M., Tosti, A., Gatti, G., Pasticci, M. B., Miletich, F., Marroni, M., Bassetti, D., & Pauluzzi, S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.838 · Cited by 94 · see citing works

Bacterial meningitis associated with lumbar drains: a retrospective cohort study

Coplin, W. M., Avellino, A. M., Kim, D. K., et al. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.468 · Cited by 93 · see citing works

Efficacy and Safety of Amphotericin B Lipid Complex in 548 Children and Adolescents With Invasive Fungal Infections

Wiley, J. M., Seibel, N. L., & Walsh, T. J. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000153183.51258.b8 · Cited by 89 · see citing works

Placebo-controlled trial of prednisone in advanced HIV-1 infection

McComsey, G. A., Whalen, C. C., Mawhorter, S. D., et al. (2001) · AIDS · doi:10.1097/00002030-200102160-00004 · Cited by 88 · see citing works

Cryptococcus gattiiInfection: Characteristics and Epidemiology of Cases Identified in a South African Province with High HIV Seroprevalence, 2002–2004

Morgan, J., McCarthy, K., Gould, S., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507897 · Cited by 87 · see citing works

Cryptococcosis in human immunodeficiency virus-infected children

Gonzalez, C. E., Shetty, D., Lewis, L. L., et al. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199609000-00012 · Cited by 85 · see citing works

Population pharmacokinetic meta-analysis with efavirenz

Barrett, J. S., Joshi, A., Chai, M., et al. (2002) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp40507 · Cited by 84 · see citing works

Fungal Infections in Transplant Recipients Receiving Alemtuzumab

Nath, D. S., Kandaswamy, R., Gruessner, R. W. G., et al. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.01.054 · Cited by 83 · see citing works

Pulmonary Cryptococcosis in the Immunocompetent Host

Núñez, M., Peacock, J. E., & Chin, R. (2000) · CHEST Journal · doi:10.1378/chest.118.2.527 · Cited by 83 · see citing works

Cryptococcal Pneumonia Complicating Pregnancy

Ely, E. W., Peacock, J. E., Haponik, E. F., et al. (1998) · Medicine · doi:10.1097/00005792-199805000-00001 · Cited by 82 · see citing works

Antifungal Management Practices and Evolution of Infection in Organ Transplant Recipients with Cryptococcus Neoformans Infection

Singh, N., Lortholary, O., Alexander, B. D., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000173774.74388.49 · Cited by 81 · see citing works

Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis

Allendoerfer, R., Marquis, A. J., Rinaldi, M. G., & Graybill, J. R. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.4.726 · Cited by 78 · see citing works

Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes

Fisher, D. A., Burrow, J. N., Lo, D., et al. (1993) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1993.tb04726.x · Cited by 78 · see citing works

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis

Milefchik, E. N., Leal, M. A. E., Haubrich, R., Bozzette, S. A., Tilles, J. G., Leedom, J. M., McCutchan, J. A., & Larsen, R. A. (2008) · Medical Mycology · doi:10.1080/13693780701851695 · Cited by 78 · see citing works

Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis

Seaton, R. A., Verma, N., Naraqi, S., et al. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90391-6 · Cited by 75 · see citing works

High-Dose Fluconazole for Treatment of Cryptococcal Disease in Patients with Human Immunodeficiency Virus Infection

Haubrich, R., Haghighat, D., Bozzette, S. A., Tilles, J. G., McCutchan, J. A., & California Collaborative Treatment Group (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.238 · Cited by 74 · see citing works

A Prospective Study of AIDS-associated Cryptococcal Meningitis in Thailand Treated with High-dose Amphotericin B

Pitisuttithum, P., Tansuphasawadikul, S., Simpson, A. J. H., Howe, P. A., & White, N. J. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0916 · Cited by 73 · see citing works

Cryptococcus neoformans Meningitis at 2 Hospitals in Washington, D.C.: Adherence of Health Care Providers to Published Practice Guidelines for the Management of Cryptococcal Disease

Shoham, S., Cover, C., Donegan, N., Fulnecky, E. J., & Kumar, P. N. (2005) · Clinical Infectious Diseases · doi:10.1086/427213 · Cited by 71 · see citing works

Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy

van Elden, L. J. R., Walenkamp, A., Lipovsky, M. M., et al. (2000) · AIDS · doi:10.1097/00002030-200012010-00019 · Cited by 68 · see citing works

Paradoxical Inflammatory Reaction during Treatment of Cryptococcus neoformans var. gattii Meningitis in an HIV-Seronegative Woman

Einsiedel, L. J., Gordon, D., & Dyer, J. R. (2004) · Clinical Infectious Diseases · doi:10.1086/424746 · Cited by 67 · see citing works

Amphotericin B as Primary Therapy for Cryptococcosis in Patients with AIDS: Reliability of Relatively High Doses Administered over a Relatively Short Period

de Lalla, F., Pellizzer, G., Vaglia, A., Manfrin, V., Franzetti, M. M., Fabris, P., & Stecca, C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.263 · Cited by 66 · see citing works

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy

Martínez, E., García-Viejo, M. A., Marcos, M. Á., et al. (2000) · AIDS · doi:10.1097/00002030-200011100-00029 · Cited by 65 · see citing works

Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review

Macsween, K. F., Bicanic, T. A., Brouwer, A. E., et al. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.02.010 · Cited by 65 · see citing works

Acute Respiratory Failure Associated With Pulmonary Cryptococcosis in Non-AIDS Patients

Vilchez, R. A., Linden, P., Lacomis, J. M., Costello, P., Fung, J. J., & Kusne, S. (2001) · CHEST Journal · doi:10.1378/chest.119.6.1865 · Cited by 65 · see citing works

Efficacy of Amphotericin B in Combination with Flucytosine against Flucytosine-Susceptible or Flucytosine-Resistant Isolates of Cryptococcus neoformans during Disseminated Murine Cryptococcosis

Schwarz, P., Dromer, F., Lortholary, O., & Dannaoui, É. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.113-120.2006 · Cited by 65 · see citing works

Acute Respiratory Failure Associated with Cryptococcosis in Patients with AIDS: Analysis of Predictive Factors

Visnegarwala, F., Graviss, E. A., Lacke, C. E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514984 · Cited by 64 · see citing works

Th2/Th3 cytokine genotypes are associated with pregnancy loss

Costeas, P., Koumouli, A., Giantsiou-Kyriakou, A., Papaloizou, A., & Koumas, L. (2004) · Human Immunology · doi:10.1016/j.humimm.2003.11.007 · Cited by 63 · see citing works

A Pilot Study of the Discontinuation of Antifungal Therapy for Disseminated Cryptococcal Disease in Patients with Acquired Immunodeficiency Syndrome, following Immunologic Response to Antiretroviral Therapy

Aberg, J. A., Price, R. W., Heeren, D. M., & Bredt, B. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/339680 · Cited by 62 · see citing works

Flucytosine Primary Resistance in Candida Species and Cryptococcus neoformans

Cuenca‐Estrella, M., Dı́az-Guerra, T. M., Mellado, E., & Rodríguez-Tudela, J. L. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011265 · Cited by 60 · see citing works

CRYPTOCOCCUS MENINGITIS ARRESTED WITH AMPHOTERICIN B

Appelbaum, E., & SHTOKALKO, S. (1957) · Annals of Internal Medicine · doi:10.7326/0003-4819-47-2-346 · Cited by 56 · see citing works

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole

Schaars, C., Meintjes, G., Morroni, C., Post, F. A., & Maartens, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-118 · Cited by 55 · see citing works

Managing Cryptococcal Meningitis Is about Handling the Pressure

Peter, G. (2005) · Clinical Infectious Diseases · doi:10.1086/427222 · Cited by 55 · see citing works

The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis

Woodworth, G. F., McGirt, M. J., Williams, M. A., et al. (2005) · Surgical Neurology · doi:10.1016/j.surneu.2004.08.069 · Cited by 55 · see citing works

Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-d-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer

Igai, H., Gotoh, M., & Yokomise, H. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.09.022 · Cited by 55 · see citing works

Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos.

Tiboni, G. M. (1993) · PubMed · Cited by 55 · see citing works

Complex Regulation of the Yeast Heat Shock Transcription Factor

Bonner, J. J., Carlson, T., Fackenthal, D. L., Paddock, D., Storey, K., & Lea, K. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1739 · Cited by 54 · see citing works

Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis

Ding, J. C., Bauer, M., Diamond, D. M., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1589 · Cited by 54 · see citing works

Successful Use of Amphotericin B Lipid Complex in the Treatment of Cryptococcosis

Baddour, L. M., Perfect, J. R., & Ostrosky‐Zeichner, L. (2005) · Clinical Infectious Diseases · doi:10.1086/429337 · Cited by 51 · see citing works

Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans

Schwarz, P., Janbon, G., Dromer, F., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00446-06 · Cited by 51 · see citing works

Cryptococcus Infection in Tropical Australia

Jenney, A. W. J., Pandithage, K., Fisher, D. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3865-3868.2004 · Cited by 50 · see citing works

CRYPTOCOCCIC MENINGITIS OF NEARLY SIXTEEN YEARS' DURATION

Beeson, P. B. (1952) · Archives of Internal Medicine · doi:10.1001/archinte.1952.00240050111008 · Cited by 49 · see citing works

Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B

the Australasian Society for Infectious Diseases (ASID) Mycoses Interest Group, & Chen, S. C. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.57 · Cited by 49 · see citing works

Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases.

Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B., O’Leary, M., & Uden, D. L. (1995) · PubMed · Cited by 48 · see citing works

Persistence of Cryptococcomas on Neuroimaging

Hospenthal, D. R., & Bennett, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/317434 · Cited by 48 · see citing works

Pancoast's Syndrome Due to Pulmonary Infection with Cryptococcus neoformans Variety gattii

Mitchell, D., & Sorrell, T. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.5.1142 · Cited by 47 · see citing works

Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory

Soltani, M., Tobin, C. M., Bowker, K. E., Sunderland, J., MacGowan, A. P., & Lovering, A. M. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.07.013 · Cited by 46 · see citing works

Cryptococcal meningitis ( C. neoformans var. gattii ) leading to blindness in previously healthy melanesian adults in Papua New Guinea

Lalloo, D. G., Fisher, D. A., Naraqi, S., et al. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068939 · Cited by 46 · see citing works

MOTHER-TO-CHILD TRANSMISSION OF CRYPTOCOCCUS NEOFORMANS

Sirinavin, S., Intusoma, U., & Tuntirungsee, S. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000115639.43305.9b · Cited by 45 · see citing works

Use of Amphotericin B During Pregnancy: Case Report and Review

Dean, J. L., Wolf, J. E., Ranzini, A. C., & Laughlin, M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.364 · Cited by 44 · see citing works

Fluconazole monotherapy for cryptococcosis in non-AIDS patients

YAMAGUCHI, H., IKEMOTO, H., Watanabe, K., et al. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01701520 · Cited by 43 · see citing works

Coccidioidomycosis complicating pregnancy

McCoy, M. J., Ellenberg, J. F., & Killam, A. P. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)33252-x · Cited by 43 · see citing works

Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease

Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B., O’Leary, M., & Uden, D. L. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04331.x · Cited by 43 · see citing works

CRYPTOCOCCAL MENINGITIS IN PREGNANCY

Philpot, C. R., & Lo, D. (1972) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1972.tb103682.x · Cited by 42 · see citing works

Systematic Screening of Cryptococcal Antigenemia in HIV-Positive Adults in Uganda

Tassie, J.-M., Pepper, L. J., Fogg, C., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200307010-00019 · Cited by 41 · see citing works

Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis

Brouwer, A. E., Siddiqui, A. A., Kester, M. I., Sigaloff, K., Rajanuwong, A., Wannapasni, S., Chierakul, W., & Harrison, T. S. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.10.002 · Cited by 41 · see citing works

Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome

Lesho, E. P. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.3.469 · Cited by 40 · see citing works

Management of cryptococcosis in non-HIV-related patients

Yao, Z., Liao, W., & Chen, R. (2004) · Medical Mycology · doi:10.1080/13693780410001731628 · Cited by 39 · see citing works

Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy.

Ismail, M. A., & Lerner, S. A. (1982) · PubMed · doi:10.1164/arrd.1982.126.2.350 · Cited by 38 · see citing works

The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus

Nelson, M. R., Bower, M., Smith, D. E., et al. (1990) · Journal of Infection · doi:10.1016/0163-4453(90)91727-u · Cited by 37 · see citing works

Management of Cryptococcal Meningitis with Extremely High Intracranial Pressure in HIV-Infected Patients

Sun, H., Hung, C., & Chang, S. (2004) · Clinical Infectious Diseases · doi:10.1086/421272 · Cited by 37 · see citing works

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole

Manosuthi, W., Athichathanabadi, C., Uttayamakul, S., et al. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-14 · Cited by 32 · see citing works

Cryptococcus gattii:in vitrosusceptibility to the new antifungal albaconazole versus fluconazole and voriconazole

Morera, Y., Torres-Rodrı́guez, J. M., Jiménez-Cabello, T., & Baró, T. (2005) · Medical Mycology · doi:10.1080/13693780400029528 · Cited by 32 · see citing works

Treatment of Experimental Cryptococcal Meningitis with Fluconazole: Impact of Dose and Addition of Flucytosine on Mycologic and Pathophysiologic Outcome

Kartalija, M., Kaye, K. S., Tureen, J. H., Liu, Q., Täuber, M. G., ELLIOTT, B. R., & Sande, M. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1216 · Cited by 32 · see citing works

Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen

Singh, N., Gayowski, T., & Marino, I. R. (1998) · Transplant International · doi:10.1007/s001470050104 · Cited by 31 · see citing works

In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs

Tay, S. T., Haryanty, T. T., Ng, K. P., et al. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01242.x · Cited by 31 · see citing works

Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen

Singh, N., Gayowski, T., & Marino, I. R. (1998) · Transplant International · doi:10.1111/j.1432-2277.1998.tb00958.x · Cited by 31 · see citing works

Cryptococcosis in renal transplant recipients.

Shaariah, W., Morad, Z., & Ab, S. (1992) · PubMed · Cited by 28 · see citing works

CATASTROPHIC VISUAL LOSS DUE TO CRYPTOCOCCUS NEOFORMANS MENINGITIS Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Medicine. 1993;72

Levin, S. (1993) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199311000-00013 · Cited by 26 · see citing works

Cryptococcosis in HIV-infected children.

Likasitwattanakul, S., Poneprasert, B., & Sirisanthana, V. (2004) · PubMed · Cited by 26 · see citing works

Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy

Rollot, F., Bossi, P., Tubiana, R., et al. (2001) · AIDS · doi:10.1097/00002030-200107270-00019 · Cited by 26 · see citing works

Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea

Laurenson, I. F., Trevett, A. J., Lalloo, D. G., et al. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90479-4 · Cited by 24 · see citing works

Cryptococcal Meningitis in a Neonate

Rawat, D., Mathur, M., Kaur, R., et al. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655402320208820 · Cited by 23 · see citing works

Coccidioidomycosis and Pregnancy

Spinello, I. M., Johnson, R. H., & Baqi, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1406.008 · Cited by 23 · see citing works

Failure of the Cryptococcal Serum Antigen Test to Detect Primary Pulmonary Cryptococcosis in Patients Infected with Human Immunodeficiency Virus

Taelman, H., Bogaerts, J., Batungwanayo, J., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.1.119 · Cited by 22 · see citing works

Cessation of secondary prophylaxis in patients with cryptococcosis

Nwokolo, N. C., Fisher, M., Gazzard, B., et al. (2001) · AIDS · doi:10.1097/00002030-200107270-00015 · Cited by 22 · see citing works

Post partum osteomyelitis due to Cryptococcus neoformans

Annapureddy, S. R., Masterson, S. W., David, H. G., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600953479 · Cited by 19 · see citing works

Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.

Tansuphaswadikul, S., Maek-a-nantawat, W., Phonrat, B., et al. (2006) · PubMed · Cited by 19 · see citing works

Ophthalmological complications of cryptococcal meningitis.

Jd, B., Danta, G., Sorrell, T. C., et al. (1985) · PubMed · Cited by 19 · see citing works

Disseminated infection withCryptococcus neoformans varneoformans in an 8 years immunocompetent girl

Chaudhary, M. W., Sardana, K., Kumar, P., et al. (2005) · The Indian Journal of Pediatrics · doi:10.1007/bf02760590 · Cited by 18 · see citing works

Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis

Manfredi, R., Coronado, O., Mastroianni, A., et al. (1997) · International Journal of STD & AIDS · doi:10.1258/0956462971920226 · Cited by 17 · see citing works

Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy

Sheng, W., Hung, C., Chen, M. Y., et al. (2002) · International Journal of STD & AIDS · doi:10.1258/095646202760326462 · Cited by 17 · see citing works

Fungal brain abscesses in leukemia.

Athanassiadou, F., Tragiannidis, A., Papageorgiou, T., et al. (2006) · PubMed · Cited by 14 · see citing works

[Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].

Negroni, R., Helou, S., Daneri, G. L., et al. (2005) · PubMed · Cited by 13 · see citing works

CUTANEOUS LESIONS OF DISSEMINATED CRYPTOCOCCOSIS AS THE PRESENTING MANIFESTATION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN A TWENTY-TWO-MONTH-OLD CHILD

Tuerlinckx, D., Bodart, E., Garrino, M.-G., et al. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200104000-00025 · Cited by 11 · see citing works

Cryptococcal infections of the central nervous system: a ten year experience.

Waterston, J. A., & Gilligan, B. S. (1987) · PubMed · Cited by 9 · see citing works

CNS cryptococcosis: unusual aspects.

Cochius, J. I., Burns, R. J., & Willoughby, J. O. (1989) · PubMed · Cited by 7 · see citing works

Nine-Year-Old Girl With Lymphangiectasia and Chest Pain

Grant, E., & Junker, A. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000168847.56321.cb · Cited by 3 · see citing works

The antifungal pipeline: a reality check

Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866 · see citing works

Emerging opportunistic yeast infections

Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70218-8 · Cited by 811 · see citing works

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA · doi:10.1001/jama.2018.8431 · Cited by 698 · see citing works

Cryptococcus: from environmental saprophyte to global pathogen

May, R. C., Stone, N. R. H., Wiesner, D. L., Bicanic, T., & Nielsen, K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.6 · Cited by 541 · see citing works

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs · doi:10.1007/s40265-016-0538-7 · Cited by 537 · see citing works

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis

Kwon-Chung, K. J., Fraser, J. A., Doering, T. L., Wang, Z. A., Janbon, G., Idnurm, A., & Bahn, Y.-S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019760 · Cited by 531 · see citing works

Fungal infections in HIV/AIDS

Limper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30303-1 · Cited by 472 · see citing works

Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis

Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418 · see citing works

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit794 · Cited by 367 · see citing works

Treatment strategies for cryptococcal infection: challenges, advances and future outlook

Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363 · see citing works

Antifungal Agents

Nett, J. E., & Andes, D. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.012 · Cited by 351 · see citing works

Epidemiology of cryptococcal meningitis in the US: 1997–2009

Pyrgos, V., Seitz, A. E., Steiner, C. A., Prevots, D. R., & Williamson, P. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056269 · Cited by 309 · see citing works

Therapy for fungal diseases: opportunities and priorities

Denning, D. W., & Hope, W. W. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.02.004 · Cited by 314 · see citing works

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290 · see citing works

Azole antifungals: 35 years of invasive fungal infection management

Allen, D., Wilson, D., Drew, R., & Perfect, J. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1032939 · Cited by 255 · see citing works

The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

Zhai, B., Wu, C., Wang, L., Sachs, M. S., & Lin, X. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00212-12 · Cited by 205 · see citing works

Cryptococcal Interactions with the Host Immune System

Voelz, K., & May, R. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00039-10 · Cited by 202 · see citing works

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

Stone, N. R. H., Rhodes, J., Fisher, M. C., Mfinanga, S., Kivuyo, S., Rugemalila, J., Segal, E. S., Needleman, L., Molloy, S. F., Kwon-Chung, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124516 · Cited by 167 · see citing works

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis

Panackal, A. A., Wuest, S. C., Lin, Y.-C., Wu, T., Zhang, N., Kosa, P., Komori, M., Blake, A., Browne, S. K., Rosen, L. B., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004884 · Cited by 162 · see citing works

Understanding the Role of T Cells in CNS Homeostasis

Ellwardt, E., Walsh, J. T., Kipnis, J., & Zipp, F. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.12.008 · Cited by 156 · see citing works

Antifungal Pharmacokinetics and Pharmacodynamics

Lepak, A. J., & Andes, D. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019653 · Cited by 134 · see citing works

<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus

Shaw, K. J., Schell, W. A., Covel, J., Duboc, G., Giamberardino, C., Kapoor, M., Moloney, M., Soltow, Q. A., Tenor, J. L., Toffaletti, D. L., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00523-18 · Cited by 121 · see citing works

Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole<i>In Vivo</i>

Butts, A., Koselny, K., Chabrier-Roselló, Y., Semighini, C. P., Brown, J. C. S., Wang, X., Annadurai, S., DiDone, L., Tabroff, J., Childers, W. E., et al. (2014) · mBio · doi:10.1128/mbio.00765-13 · Cited by 102 · see citing works

Management of invasive fungal infections: a role for polyenes

Chandrasekar, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq479 · Cited by 100 · see citing works

Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi

Delma, F. Z., Al-Hatmi, A. M. S., Brüggemann, R. J. M., Melchers, W. J. G., de Hoog, S., Verweij, P. E., & Buil, J. B. (2021) · Journal of Fungi · doi:10.3390/jof7110909 · Cited by 96 · see citing works

Application of Dendrimers for the Treatment of Infectious Diseases

Mhlwatika, Z., & Aderibigbe, B. A. (2018) · Molecules · doi:10.3390/molecules23092205 · Cited by 97 · see citing works

A Repurposing Approach Identifies Off-Patent Drugs with Fungicidal Cryptococcal Activity, a Common Structural Chemotype, and Pharmacological Properties Relevant to the Treatment of Cryptococcosis

Butts, A., DiDone, L., Koselny, K., Baxter, B. K., Chabrier-Rosello, Y., Wellington, M., & Krysan, D. J. (2013) · Eukaryotic Cell · doi:10.1128/ec.00314-12 · Cited by 95 · see citing works

Preclinical assessment of a fully automated multiplex PCR panel for detection of central nervous system pathogens

Hanson, K. E., Slechta, E. S., Killpack, J. A., Heyrend, C., Lunt, T., Daly, J. A., Hemmert, A. C., & Blaschke, A. J. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02850-15 · Cited by 86 · see citing works

Brain Inositol Is a Novel Stimulator for Promoting Cryptococcus Penetration of the Blood-Brain Barrier

Liu, T.-B., Kim, J.-C., Wang, Y., Toffaletti, D. L., Eugenin, E., Perfect, J. R., Kim, K. J., & Xue, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003247 · Cited by 89 · see citing works

Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans

Huang, W., Liao, G., Baker, G. M., Wang, Y., Lau, R., Paderu, P., Perlin, D. S., & Xue, C. (2016) · mBio · doi:10.1128/mbio.00478-16 · Cited by 88 · see citing works

Stress Signaling Pathways for the Pathogenicity of Cryptococcus

Bahn, Y.-S., & Jung, K.-W. (2013) · Eukaryotic Cell · doi:10.1128/ec.00218-13 · Cited by 84 · see citing works

Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial

Jarvis, J. N., Leeme, T. B., Molefi, M., Chofle, A. A., Bidwell, G., Tsholo, K., Tlhako, N., Mawoko, N., Patel, R. K. K., Tenforde, M. W., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy515 · Cited by 86 · see citing works

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications

Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82 · see citing works

A titanic drug resistance threat in Cryptococcus neoformans

Zafar, H., Altamirano, S., Ballou, E. R., & Nielsen, K. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.11.001 · Cited by 76 · see citing works

Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans

Bastos, R. W., Carneiro, H. C. S., Oliveira, L. V. N., Rocha, K. M., Freitas, G. J. C., Costa, M. C., Magalhães, T. F. F., Carvalho, V. S. D., Rocha, C. E., Ferreira, G. F., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01179-17 · Cited by 72 · see citing works

The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent <i>In Vitro</i> Activity against Cryptococcus neoformans and Cryptococcus gattii

Lockhart, S. R., Fothergill, A. W., Iqbal, N., Bolden, C. B., Grossman, N. T., Garvey, E. P., Brand, S. R., Hoekstra, W. J., Schotzinger, R. J., Ottinger, E., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02770-15 · Cited by 67 · see citing works

Confronting antifungal resistance, tolerance, and persistence: advances in drug target discovery and delivery systems

Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63 · see citing works

Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans

Ngamskulrungroj, P., Chang, Y., Hansen, B., Bugge, C., Fischer, E., & Kwon-Chung, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033022 · Cited by 56 · see citing works

Adaptation to Fluconazole Via Aneuploidy Enables Cross‐Adaptation to Amphotericin B and Flucytosine in Cryptococcus Neoformans

Yang, F., Gritsenko, V., Lu, H., Zhen, C., Gao, L., Berman, J., & Jiang, Y.-Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00723-21 · Cited by 49 · see citing works

Commentary: The First Fully Automated Molecular Diagnostic Panel for Meningitis and Encephalitis: How Well Does It Perform, and When Should It Be Used?

Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01255-16 · Cited by 52 · see citing works

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen

Nishikawa, H., Fukuda, Y., Mitsuyama, J., Tashiro, M., Tanaka, A., Takazono, T., Saijo, T., Yamamoto, K., Nakamura, S., Imamura, Y., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx020 · Cited by 51 · see citing works

Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and <i>Candida</i> spp

Rossi, S. A., de Oliveira, H. C., Agreda-Mellon, D., Lucio, J., Mendes-Giannini, M. J. S., García-Cambero, J. P., & Zaragoza, O. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01921-19 · Cited by 48 · see citing works

Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii

Ferreira, G. F., Santos, J. R. A., Costa, M. C. D., Holanda, R. A. D., Denadai, Â. M. L., Freitas, G. J. C. D., Santos, Á. R. C., Tavares, P. B., Paixão, T. A., & Santos, D. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00466-15 · Cited by 44 · see citing works

Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?

Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., & Lass-Flörl, C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.017 · Cited by 40 · see citing works

The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis

Garvey, E. P., Sharp, A. D., Warn, P. A., Yates, C. M., & Schotzinger, R. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky242 · Cited by 39 · see citing works

Antifungals in Clinical Use and the Pipeline

Johnson, M. D. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.005 · Cited by 35 · see citing works

Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: A single Mexican center experience

Villanueva-Lozano, H., Treviño-Rangel, R. D. J., González, G. M., Hernández-Rodríguez, P. A., Camacho-Ortiz, A., Castillo-Reyna, L., Galindo-Alvarado, S. G., & Martínez-Reséndez, M. F. (2018) · Infection · doi:10.1007/s15010-017-1059-3 · Cited by 35 · see citing works

Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress

Chang, Y. C., Khanal Lamichhane, A., & Kwon-Chung, K. J. (2018) · mBio · doi:10.1128/mbio.01290-18 · Cited by 34 · see citing works

From the environment to the host: How non-azole agrochemical exposure affects the antifungal susceptibility and virulence of Cryptococcus gattii

Bastos, R. W., Freitas, G. J. C., Carneiro, H. C. S., Oliveira, L. V. N., Gouveia-Eufrasio, L., Santos, A. P. N., Moyrand, F., Maufrais, C., Janbon, G., & Santos, D. A. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.094 · Cited by 35 · see citing works

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.

Ngan, N. T. T., Mai, N. T. H., Tung, N. L. N., Lan, N. P. H., Tai, L. T. H., Phu, N. H., Chau, N. V. V., Binh, T. Q., Hung, L. Q., Beardsley, J., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15010.1 · Cited by 28 · see citing works

The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis

Wiederhold, N. P., Najvar, L. K., Garvey, E. P., Brand, S. R., Xu, X., Ottinger, E. A., Alimardanov, A., Cradock, J., Behnke, M., Hoekstra, W. J., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01071-18 · Cited by 27 · see citing works

Investigation of fluconazole heteroresistance in clinical and environmental isolates of <i>Cryptococcus neoformans</i> complex and <i>Cryptococcus gattii</i> complex in the state of Amazonas, Brazil

Moreira, I. D. M. B., Cortez, A. C. A., de Souza, É. S., Pinheiro, S. B., de Souza Oliveira, J. G., Sadahiro, A., Cruz, K. S., Matsuura, A. B. J., Melhem, M. D. S. C., Frickmann, H., et al. (2022) · Medical Mycology · doi:10.1093/mmy/myac005 · Cited by 22 · see citing works

Colony and Single Cell Level Analysis of the Heterogeneous Response of Cryptococcus neoformans to Fluconazole

Altamirano, S., Simmons, C., & Kozubowski, L. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00203 · Cited by 19 · see citing works

Evaluation of the in vitro activity of amphotericin B by time–kill curve methodology against large and small capsulate C. neoformans isolates

Córdoba, S., Afeltra, J., & Vitale, R. G. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.08.003 · Cited by 17 · see citing works

Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections

Schiave, L. A., Nascimento, E., Vilar, F. C., de Haes, T. M., Takayanagui, O. M., Gaitani, C. M. D., & Martinez, R. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.10.003 · Cited by 15 · see citing works

Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study

Liu, J., Liu, J., Su, X., Yang, L., Wang, Y., Wang, A., Xu, X., Li, M., Jiang, Y., & Peng, F. (2022) · BMC Neurology · doi:10.1186/s12883-022-02803-1 · Cited by 14 · see citing works

Thiazole derivatives act on virulence factors of <i>Cryptococcus</i> spp.

de Sá, N. P., de Barros, P. P., Junqueira, J. C., Vaz, J. A., de Oliveira, R. B., Rosa, C. A., Santos, D. A., & Johann, S. (2019) · Medical Mycology · doi:10.1093/mmy/myx158 · Cited by 13 · see citing works

Changing demographics and risk factors for cryptococcosis: A 12-year review at a tertiary care centre.

Bhatt, M., Porterfield, J. Z., Ribes, J. A., Arora, V., & Myint, T. (2021) · Mycoses · doi:10.1111/myc.13323 · Cited by 13 · see citing works

Epidemiology of cryptococcal meningitis and fluconazole heteroresistance in <i>Cryptococcus neoformans</i> isolates from a teaching hospital in southwestern China

Huang, Y., Zhang, Y., Yang, S., Lu, H., Yu, H., Wang, X., Jia, X., Tang, D., Wu, L., Huang, S., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00725-24 · Cited by 12 · see citing works

Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans

Oliveira, N. K., Bhattacharya, S., Gambhir, R., Joshi, M., & Fries, B. C. (2022) · doi:10.20944/preprints202201.0263.v1 · Cited by 24 · see citing works

Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcusspecies and literature review

Bernal‐Martínez, L., Gómez‐López, A., Castelli, M. V., et al. (2010) · Medical Mycology · doi:10.3109/13693780902756073 · Cited by 61 · see citing works

The Primary Target Organ of Cryptococcus gattii Is Different from That of Cryptococcus neoformans in a Murine Model

Ngamskulrungroj, P., Chang, Y. C., Sionov, E., & Kwon-Chung, K. J. (2012) · mBio · doi:10.1128/mbio.00103-12 · Cited by 152 · see citing works

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

Cevallos, E. C., Yetmar, Z. A., & Razonable, R. R. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa527 · Cited by 31 · see citing works

Recent Advances in the Ecoepidemiology, Virulence and Diagnosis of Cryptococcus neoformans and Cryptococcus gattii Species Complexes

Kenosi, K., Jongman, M., Daniel, L., & Ishmael, K. (2023) · The Open Microbiology Journal · doi:10.2174/18742858-v17-e230419-2022-28 · Cited by 4 · see citing works

Visible DNA microarray and loop-mediated isothermal amplification (LAMP) for the identification of Cryptococcus species recovered from culture medium and cerebrospinal fluid of patients with meningitis

Stivanelli, P., Tararam, C. A., Trabasso, P., et al. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209056 · Cited by 5 · see citing works